Yuxiang Wang
Yuxiang Wang
1Division of Anti-Tumor Pharmacology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China
2University of Chinese Academy of Sciences, Beijing 100049, China
1,2,
Xian Li
Xian Li
1Division of Anti-Tumor Pharmacology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China
1,
Xueling Liu
Xueling Liu
1Division of Anti-Tumor Pharmacology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China
2University of Chinese Academy of Sciences, Beijing 100049, China
1,2,
Yi Chen
Yi Chen
2University of Chinese Academy of Sciences, Beijing 100049, China
3Division of Anti-Tumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China
2,3,
Chunhao Yang
Chunhao Yang
4Department of Medicinal Chemistry, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 200120, China
4,
Cun Tan
Cun Tan
4Department of Medicinal Chemistry, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 200120, China
4,
Bobo Wang
Bobo Wang
1Division of Anti-Tumor Pharmacology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China
1,
Yiming Sun
Yiming Sun
2University of Chinese Academy of Sciences, Beijing 100049, China
3Division of Anti-Tumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China
2,3,
Xi Zhang
Xi Zhang
1Division of Anti-Tumor Pharmacology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China
1,
Yinglei Gao
Yinglei Gao
2University of Chinese Academy of Sciences, Beijing 100049, China
3Division of Anti-Tumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China
2,3,
Jian Ding
Jian Ding
2University of Chinese Academy of Sciences, Beijing 100049, China
3Division of Anti-Tumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China
2,3,*,
Linghua Meng
Linghua Meng
1Division of Anti-Tumor Pharmacology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China
2University of Chinese Academy of Sciences, Beijing 100049, China
1,2,*
1Division of Anti-Tumor Pharmacology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China
2University of Chinese Academy of Sciences, Beijing 100049, China
3Division of Anti-Tumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China
4Department of Medicinal Chemistry, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 200120, China
*Jian Ding E-mail:
jding@simm.ac.cn
*Linghua Meng
lhmeng@simm.ac.cn
Received 2019 Nov 25; Accepted 2019 Nov 28.